Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
MERTK Blocking Peptide (AC1153)
Cat.#: ACPP-1153
Specifications
Despition MERTK Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1169 proBNP Blocking Peptide (AC1169) 250 µg inquiry ACPP-1046 Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) 50 µg inquiry ACPP-1418 Human GAL Protein (AC1418) 2 µg inquiry ACPP-1779 Human HSD17B10 Protein (AC1779) 5 µg inquiry ACPP-1550 Rat FGF 1 Protein (AC1550) 10 µg inquiry ACPP-1264 SorLA Blocking Peptide (AC1264) 250 µg inquiry ACPP-1047 Recombinant Human Myelin Basic Protein Protein (Fc Tag) (AC1047) 50 µg inquiry ACPP-1328 MRAP2 Blocking Peptide (AC1328) 250 µg inquiry ACPP-1838 Human APO D Protein, GST (AC1838) 2 µg inquiry ACPP-1306 FGFR2 Blocking Peptide (AC1306) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket